EPA shows promise for migraine reliefA 12-week randomized double-blind clinical trial of eicosapentaenoic acid intervention in episodic migraine.
We examined the effects of eicosapentaenoic acid (EPA) on episodic migraine patients through a 12-week randomized double-blind trial. Seventy participants were divided into two groups, one receiving EPA and the other a placebo.
Those taking the EPA experienced significant decreases in migraine frequency, medication use, headache severity, and improvements in overall quality of life.
Notably, women benefitted particularly from this treatment. Overall, high-dose EPA showed promise as an effective preventive option for episodic migraines, with no major side effects observed.
Energy boost
Most Useful Review
Good composition, quick delivery, high-quality packaging with no damage. The capsules are a bit large, but easy to swallow, and taste like citrus. I take one daily with meals alongside vitamin D3+K2 and magnesium. After 10 days, I’ve noticed benefits; my frequent headaches, nausea, and fatigue have ceased. I’m more energised and my mood is excellent. Perfect for those into sports or on a diet. Omega-3 truly revitalises the body!